Hélène Bouraïma-Lelong

Dr. Hélène Bouraïma-Lelong


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in General and Comparative Endocrinology
Verified
Journal Article
Closed access
BABrahim Arkoun
Brahim Arkoun
CGCamille Gautier
Camille Gautier
CDChristelle Delalande
Christelle Delalande
IBIsabelle Barrier-Battut
Isabelle Barrier-Battut
IGIsabelle Guénon
Isabelle Guénon
HBHélène Bouraïma-Lelong
Hélène Bouraïma-Lelong

8 May 2017 in Basic and Clinical Andrology
Verified
Journal Article
Open access
PDF file
AZAna Paula Zanatta
Ana Paula Zanatta
VBVanessa Brouard
Vanessa Brouard
CGCamille Gautier
Camille Gautier
RGRenata Goncalves
Renata Goncalves
HBHélène Bouraïma-Lelong
Hélène Bouraïma-Lelong
CDChristelle Delalande
Christelle Delalande
Oestrogens and 1α,25(OH)2-vitamin D3 (1,25-D3) are steroids that can provide effects by binding to their receptors localised in the cytoplasm and in the nucleus or the plasma membrane respectively inducing genomic and non-genomic effects. As confirmed notably by invalidation of the genes, coding for their receptors as tested with mice with in vivo and in vitro treatments, oestrogens and 1,25-D3 are regulators of spermatogenesis. Moreover, some functions of ejaculated spermatozoa as viability, DNA integrity, motility, capacitation, acrosome reaction and fertilizing ability are targets for these hormones. The studies conducted on their mechanisms of action, even though not completely elicited, have allowed the demonstration of putative interactions between their signalling pathways that are worth examining more closely. The present review focuses on the elements regulated by oestrogens and 1,25-D3 in the testis and spermatozoa as well as the interactions between the signalling pathways of both hormones.

1 July 2016 in General and Comparative Endocrinology
Verified
Journal Article
Closed access
CGCamille Gautier
Camille Gautier
IBIsabelle Barrier-Battut
Isabelle Barrier-Battut
IGIsabelle Guénon
Isabelle Guénon
DGDidier Goux
Didier Goux
CDChristelle Delalande
Christelle Delalande
HBHélène Bouraïma-Lelong
Hélène Bouraïma-Lelong

Verified
Journal Article
Open access
PDF file
MRMarion Rouge
Marion Rouge
FLflorence legendre
florence legendre
RERazan Elkhatib
Razan Elkhatib
CDChristelle Delalande
Christelle Delalande
JCJuliette Cognie
Juliette Cognie
HBHélène Bouraïma-Lelong
Hélène Bouraïma-Lelong
The castration of stallions is traditionally performed after puberty, at around the age of 2 years old. No studies have focused on the effects of early castration on osteoarticular metabolism. Thus, we aimed to compare early castration (3 days after birth) with traditional castration (18 months of age) in horses. Testosterone and estradiol levels were monitored from birth to 33 months in both groups. We quantified the levels of biomarkers of cartilage and bone anabolism (CPII and N-MID) and catabolism (CTX-I and CTX-II), as well as of osteoarthritis (HA and COMP) and inflammation (IL-6 and PGE2). We observed a lack of parallelism between testosterone and estradiol synthesis after birth and during puberty in both groups. The extra-gonadal synthesis of steroids was observed around the 28-month mark, regardless of the castration age. We found the expression of estrogen receptor (ESR1) in cartilage and bone, whereas androgen receptor (AR) expression appeared to be restricted to bone. Nevertheless, with respect to osteoarticular metabolism, steroid hormone deprivation resulting from early castration had no discernable impact on the levels of biomarkers related to bone and cartilage metabolism, nor on those associated with OA and inflammation. Consequently, our research demonstrated that early castration does not disrupt bone and cartilage homeostasis.

29 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
MRMarion Rouge
Marion Rouge
FLflorence legendre
florence legendre
RERazan Elkhatib
Razan Elkhatib
CDChristelle Delalande
Christelle Delalande
JCJuliette Cognie
Juliette Cognie
HBHélène Bouraïma-Lelong
Hélène Bouraïma-Lelong
Castration of stallions is traditionally performed after puberty around the age of 2 years old. No studies have focused on the effects of early castration on osteoarticular metabolism. Thus, we sought to compare early castration (3 days after birth) with traditional castration (18 months of age) in horses. Testosterone and estradiol levels were monitored from birth to 33 months in these two groups. We quantified the levels of biomarkers of cartilage and bone anabolism (CPII and N-MID) and catabolism (CTX-I and CTX-II), of osteoarthritis (HA and COMP) and inflammation (IL-6 and PGE2). We revealed a lack of parallelism between testosterone and estradiol syntheses after birth and during puberty in both groups. An extra-gonadal synthesis of steroids was observed around the 28 month-mark, regardless of the castration age. We found the expression of estrogen receptor (ESR1) in cartilage and bone, whereas androgen receptor (AR) expression appeared to be restricted to bone. Nevertheless, with regards to osteoarticular metabolism, steroid hormone deprivation resulting from early castration showed no discernable impact on the levels of biomarkers related to bone and cartilage metabolism, nor on those associated with OA and inflammation. Consequently, our research demonstrated that early castration does not disrupt bone and cartilage homeostasis.

2 April 2025 in La Revue de l'Infirmière
Verified
Journal Article
Closed access
HBHélène Bouraïma-Lelong
Hélène Bouraïma-Lelong
JDJulie Delaunay
Julie Delaunay
HNHervé Normand
Hervé Normand
ALAlban Lepailleur
Alban Lepailleur
SGSonia Guillouët
Sonia Guillouët